These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 8118750

  • 1. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C.
    Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
    [Abstract] [Full Text] [Related]

  • 2. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
    Hassager C, Jensen LT, Johansen JS, Riis BJ, Melkko J, Pødenphant J, Risteli L, Christiansen C, Risteli J.
    Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
    [Abstract] [Full Text] [Related]

  • 3. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen.
    Hassager C, Risteli J, Risteli L, Christiansen C.
    Osteoporos Int; 1994 Nov; 4(6):349-52. PubMed ID: 7696831
    [Abstract] [Full Text] [Related]

  • 4. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS, Hassager C, Pødenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C.
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [Abstract] [Full Text] [Related]

  • 5. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C, AgnusDei D, Gonnelli S, Nardi P.
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [Abstract] [Full Text] [Related]

  • 6. Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links.
    Välimäki MJ, Tähtelä R, Jones JD, Peterson JM, Riggs BL.
    Eur J Endocrinol; 1994 Sep; 131(3):258-62. PubMed ID: 7921210
    [Abstract] [Full Text] [Related]

  • 7. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, Weaver DS.
    Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
    [Abstract] [Full Text] [Related]

  • 8. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 Apr; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
    Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S.
    Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
    [Abstract] [Full Text] [Related]

  • 14. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin.
    Sairanen S, Tähtelä R, Laitinen K, Karonen SL, Välimäki MJ.
    Calcif Tissue Int; 1994 Nov; 55(5):349-52. PubMed ID: 7866915
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.